Cells (Nov 2021)

Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases

  • Derek Strassheim,
  • Timothy Sullivan,
  • David C. Irwin,
  • Evgenia Gerasimovskaya,
  • Tim Lahm,
  • Dwight J. Klemm,
  • Edward C. Dempsey,
  • Kurt R. Stenmark,
  • Vijaya Karoor

DOI
https://doi.org/10.3390/cells10123347
Journal volume & issue
Vol. 10, no. 12
p. 3347

Abstract

Read online

G protein-coupled receptors (GPCRs) have originally been described as a family of receptors activated by hormones, neurotransmitters, and other mediators. However, in recent years GPCRs have shown to bind endogenous metabolites, which serve functions other than as signaling mediators. These receptors respond to fatty acids, mono- and disaccharides, amino acids, or various intermediates and products of metabolism, including ketone bodies, lactate, succinate, or bile acids. Given that many of these metabolic processes are dysregulated under pathological conditions, including diabetes, dyslipidemia, and obesity, receptors of endogenous metabolites have also been recognized as potential drug targets to prevent and/or treat metabolic and cardiovascular diseases. This review describes G protein-coupled receptors activated by endogenous metabolites and summarizes their physiological, pathophysiological, and potential pharmacological roles.

Keywords